Calliditas Therapeutics
clinical advisory board comprising world leading specialists | Calliditas Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
38 of 38
Related slides by other companies
Genelux
Investor Presentation
December 2023
accomplished clinical advisory board | Genelux
Alkermes
Investor Day
March 2021
strategic planning and execution integrates ongoing feedback from external advisory boards dedicated and oncology scientific advisory boards comprised of leading experts in medicinal chemistry translational medicine and academic science offer insight into current scientific state of the art approaches provide independent program assessments identify opportunities to risk and or accelerate programs engage routinely with internal teams to address emerging challenges clinical advisory boards comprised of global thought leaders in areas of therapeutic focus validate clinical trial designs support selections advise on regulatory strategy and expedited pathways provide insights on disease landscape | Alkermes
Genprex
Investor Presentation
October 2022
meet our team | Genprex
Genelux
Investor Presentation
July 2023
accomplished clinical advisory board | Genelux
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights